Use of gemcitabine- (Gem) and fluropyrimidine (FP)-based chemotherapy to reduce myeloid-derived suppressor cells (MDSCs) in pancreatic (PC) and esophagogastric cancer (EGC).

RF Gabitass; NE Annels; J Crawshaw; HS Pandha; GW Middleton

Back

Use of gemcitabine- (Gem) and fluropyrimidine (FP)-based chemotherapy to reduce myeloid-derived suppressor cells (MDSCs) in pancreatic (PC) and esophagogastric cancer (EGC).

Journal article

Peer reviewed

Use of gemcitabine- (Gem) and fluropyrimidine (FP)-based chemotherapy to reduce myeloid-derived suppressor cells (MDSCs) in pancreatic (PC) and esophagogastric cancer (EGC).

RF Gabitass, NE Annels, J Crawshaw, HS Pandha and GW Middleton

JOURNAL OF CLINICAL ONCOLOGY, Vol.29(15)

20/05/2011

Abstract

Science & Technology

Life Sciences & Biomedicine

Oncology

Files and links (1)

url

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208880301403&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11d2a86992e85fb529977dad66a846d5View

Author

Metrics

27 Record Views

Details

Title: Use of gemcitabine- (Gem) and fluropyrimidine (FP)-based chemotherapy to reduce myeloid-derived suppressor cells (MDSCs) in pancreatic (PC) and esophagogastric cancer (EGC).
Creators: RF Gabitass
NE Annels
J Crawshaw
HS Pandha
GW Middleton
Publication Details: JOURNAL OF CLINICAL ONCOLOGY, Vol.29(15)
Publisher: AMER SOC CLINICAL ONCOLOGY
Date published: 20/05/2011
Date submitted: 17/05/2017
Identifiers: 99515392302346
Academic Unit: University of Surrey
Language: English
Resource Type: Journal article

Use of gemcitabine- (Gem) and fluropyrimidine (FP)-based chemotherapy to reduce myeloid-derived suppressor cells (MDSCs) in pancreatic (PC) and esophagogastric cancer (EGC).

Abstract

Files and links (1)

Metrics

Details

Usage Policy